Trials / Sponsors / Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Industry · 6 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | FHND1002 for ALS Treatment: Phase 2 Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | 2025-10-01 |
| Enrolling By Invitation | Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Cond Epilepsy (treatment Refractory) | Phase 1 | 2024-10-21 |
| Enrolling By Invitation | Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | 2024-07-05 |
| Unknown | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity Advanced Solid Tumors | Phase 1 | 2022-07-07 |
| Unknown | A Study Evaluating Safety, Tolerability and Clinical Activity of FHND6091 in Patients With Multiple Myeloma Multiple Myeloma | Phase 1 | 2021-12-22 |
| Enrolling By Invitation | FHND9041 Versus Afatinib for Non-small Cell Lung Cancer Non Small Cell Lung Cancer | Phase 3 | 2021-08-01 |